Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined hepatocellular-cholangiocarcinoma: An update
Aurélie Beaufrère, Julien Caldéraro, Valérie Paradis
Journal of Hepatology (2021) Vol. 74, Iss. 5, pp. 1212-1224
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

Hepatocellular carcinoma
Arndt Vogel, Tim Meyer, Gonzalo Sapisochín, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1345-1362
Closed Access | Times Cited: 1345
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
Matthias Pinter, Bernhard Scheiner, David J. Pinato
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 8, pp. 760-770
Closed Access | Times Cited: 59
Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases
Anita K. Bakrania, Narottam Joshi, Xun Zhao, et al.
Pharmacological Research (2023) Vol. 189, pp. 106706-106706
Open Access | Times Cited: 40
Multidisciplinary care for patients with HCC: a systematic review and meta-analysis
Karim Seif El Dahan, Annika Reczek, Darine Daher, et al.
Hepatology Communications (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 40
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Julien Caldéraro, Narmin Ghaffari Laleh, Qinghe Zeng, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges
Shunzhen Zheng, Siew Wee Chan, Fei Liu, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1582-1582
Open Access | Times Cited: 15
MRI-based deep learning radiomics to differentiate dual-phenotype hepatocellular carcinoma from HCC and intrahepatic cholangiocarcinoma: a multicenter study
Qian Wu, Tao Zhang, Fan Xu, et al.
Insights into Imaging (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma
Yang Zhou, Guofeng Zhou, Jiulou Zhang, et al.
European Radiology (2022) Vol. 32, Iss. 7, pp. 5004-5015
Closed Access | Times Cited: 31
Primary liver cancer classification from routine tumour biopsy using weakly supervised deep learning
Aurélie Beaufrère, Nora Ouzir, Paul Emile Zafar, et al.
JHEP Reports (2024) Vol. 6, Iss. 3, pp. 101008-101008
Open Access | Times Cited: 8
Focal liver lesion diagnosis with deep learning and multistage CT imaging
Yi Wei, Meiyi Yang, Meng ZHANG, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
MR radiomics to predict microvascular invasion status and biological process in combined hepatocellular carcinoma-cholangiocarcinoma
Yuyao Xiao, Fei Wu, Kai Hou, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma
Julien Caldéraro, Luca Di Tommaso, Pascale Maillé, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1586-1597
Open Access | Times Cited: 26
Cholangiokines: undervalued modulators in the hepatic microenvironment
Xiurong Cai, Frank Tacke, Adrien Guillot, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Liangtao Ye, Julia S. Schneider, Najib Ben Khaled, et al.
Liver Cancer (2023) Vol. 13, Iss. 1, pp. 6-28
Open Access | Times Cited: 15
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things
Yuan Fang, Xiaoli Zhang, Hanfei Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Intense 18F-FAPI Uptake in Small Recurrent Lesions of Combined Hepatocellular-Cholangiocarcinoma Negative on 18F-FDG PET/CT
Jiucen Liang, Jing Zhang, Jingjing Song, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 7, pp. e351-e353
Closed Access | Times Cited: 5
The resistance to anoikis, mediated by Spp1, and the evasion of immune surveillance facilitate the invasion and metastasis of hepatocellular carcinoma
Zhengwei Zhang, Xiaoning Chen, Yapeng Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1564-1583
Open Access | Times Cited: 5
Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit
Alexa Childs, Nekisa Zakeri, Yuk Ting, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 10, pp. 1350-1355
Open Access | Times Cited: 29
Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
Joon Hyuk Choi, Jae Y. Ro
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1826-1826
Open Access | Times Cited: 19
Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma—a European multicenter cohort
Katharina Pomej, Lorenz Balcar, Kateryna Shmanko, et al.
ESMO Open (2023) Vol. 8, Iss. 1, pp. 100783-100783
Open Access | Times Cited: 13
Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms
Simonetta Lugari, Enrica Baldelli, Amedeo Lonardo
Metabolism and Target Organ Damage (2023) Vol. 3, Iss. 1, pp. 5-5
Open Access | Times Cited: 12
Peripheral Lymphocytes in Primary Liver Cancers: Elevated NK and CD8+ T Cells and Dysregulated Selenium Metabolism
Cheng Zhou, Zhufeng Lu, Bao‐Ye Sun, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 222-222
Open Access | Times Cited: 4
GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma
Zheng Yin, Qi Liu, Ying Gao, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 5, pp. 912-925
Closed Access | Times Cited: 4
PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1
Fuqiang Huang, Jing Guo, Na Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Research progress and application of liver organoids for disease modeling and regenerative therapy
Yang Hu, Qiao Geng, L. Wang, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 7, pp. 859-874
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top